Note 3 - Accrued Liabilities

6 Months Ended

Jun. 30, 2017

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

3. Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

	At
	June 30, 2017		December 30, 2016
Research and development	$	547	$	165
Inventory		408		547
Regulatory, clinical and quality		405		640
Operations engagement fee		200		600
Sales and marketing		164		—
Warranty reserve		154		98
Deferred revenue		148		—
Legal		125		98
Information technology system and infrastructure implementations		120		327
Interest		102		99
Sales and use tax		55		56
Travel and entertainment		—		285
Accrued other		425		440
Total accrued liabilities	$	2,853	$	3,355